NFE2L2 and cancer: The expressions of NRF2 target gene Nqo1 and Gsta4 were also downregulated in the DKO 3LL cell line, demonstrating successful reversal of NRF2 hyperactivation in the KEAP1-KO cancer cells (Figures S5D and S5E).